Posted on March 9th, 2010 by Health News
SteroidAlternatives.com has launched a cutting-edge line of legal, powerful, and safe alternatives to dangerous and illegal anabolic steroids. All products offered by SteroidAlternatives.com are WADA (World Anti-Doping Agency) and IOC (International Olympic Committee) compliant. This line of products is effective and offers the consumer a legal way to build superior muscle, strength, and speed without having to resort to taking harmful, illegal substances.
Read more
Filed under: Pharmacy News
Tags: anabolic, muscle, Pharmacy, steroid
Related posts
- Anabolic steroids do not appear to contribute to CTE (0)
Anabolic steroids don't appear to contribute to degenerative brain disease caused by repeated head trauma in athletes, according to a study in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
Read more
[tags] Pharmacy News [/tags]
- Zocor, Crestor drugs may cause serious muscle and kidney problems (0)
Crestor and Zocor are widely-used prescription strength drugs designed to lower "bad cholesterol". Both drugs are classified as "statins", medicine which lowers blood cholesterol levels by inhibiting HMG-CoA reductase.
Read more
[tags] Pharmacy News [/tags]
- Winners Of Glaxosmithkline International Achievement Award Announced At BPC (0)
Professor Barry Potter, Professor of Medicinal & Biological Chemistry at the University of Bath, and the late Professor Michael Reed, Professor of Steroid Biochemistry at Imperial College, London, have won the prestigious 2009 GlaxoSmithKline (GSK) International Achievement Award.
Read more
[tags] Pharmacy News [/tags]
- VUMC doctors to begin statin drug screening for rare genetic variation (0)
Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
Read more
[tags] Pharmacy News [/tags]
- Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences (0)
Endo Pharmaceuticals and Bioniche Life Sciences Inc. today announced plans for peer-reviewed presentation of interim efficacy and safety results from the first Phase III trial of the intravesical formulation of Mycobacterial cell wall-DNA complex (MCC), known as Urocidin™ or EN3348.
Read more
[tags] Pharmacy News [/tags]
Leave a Reply